Treatment for Uncomplicated Uti

Medically reviewed by Cordelia Nwankwo, MD An uncomplicated urinary tract infection (UTI) can sometimes go away on its own without treatment. This is especially true for a UTI without symptoms, known as asymptomatic bacteriuria.

Time on MSN · 2d

There's a New Pill to Treat UTIs

On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years. The medication, gepotidacin, targets E. coli bacteria, which is responsible for the most common types of infections,

unbranded - Newsworthy on MSN · 17h

FDA Approves New Antibiotic For Treating UTIs

The Food and Drug Administration has approved Blujepa, the first antibiotic in a new class to treat urinary tract infections in nearly 30 years. Developed by GSK, Blujepa is approved for women and girls 12 and older with uncomplicated UTIs,

Interesting Engineering on MSN · 1d

New hope for UTI patients as FDA approves first-of-its-kind antibiotic in 30 years

The U.S. Food and Drug Administration (FDA) has approved a new class of antibiotics for treating uncomplicated urinary tract infections (uUTIs) in women and young girls, in a first approval of its kind in nearly 30 years.

McKnight's Long-Term Care News7h

FDA approves gepotidacin antibiotic for uncomplicated urinary tract infections

The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...

14hon MSN

Can GSK's Blujepa provide relief from UTIs amid rising bacterial resistance and declining treatment efficacy?

The US Food and Drug Administration (FDA) has early this week approved GSK's new antibiotic, Blujepa (gepotidacin), for the ...

Millions of women get painful UTIs that keep coming back. A new kind of antibiotic may help break the cycle

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...

PharmExec1d

FDA Approves GSK’s Blujepa for Uncomplicated Urinary Tract Infections

Blujepa marks the first new oral antibiotic to gain FDA approval for uncomplicated urinary tract infections in nearly 30 ...

MedCity News1d

FDA Approves First-in-Class GSK Antibiotic for Common Type of Urinary Tract Infection

The regulatory decision announced Tuesday covers the treatment of female adults and pediatric patients age 12 and older who have uncomplicated urinary tract infections, or uUTIs. The drug ...

US approves new antibiotic for urinary tract infections

US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 ...

2don MSN

FDA Approves New Oral Antibiotic Blujepa For UTI Treatment In Women And Teens

The FDA has approved Blujepa (gepotidacin), a first-in-class oral antibiotic for uncomplicated urinary tract infections (uUTIs) in women and children aged 12 and older. Clinical trials showed its ...

Clinical Advisor19h

FDA Approves Blujepa for Uncomplicated UTI in Female Patients

Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.

Morningstar2d

GSK's Treatment for Uncomplicated Urinary Tract Infections Approved in U.S.

GSK said the U.S. Food and Drug Administration approved its Blujepa oral antibiotic for the treatment of female adults and children with uncomplicated urinary tract infections. The ...

GSK receives FDA approval of Blujepa for treatment of uncomplicated UTIs

Blujepa was approved by the FDA for the treatment of female adult and pediatric patients 12 years of age and older weighing at ...

ETX Daily Up on MSN2d

"Crucial Milestone": US Approves New Antibiotic For Urinary Tract Infections

The product -- called Blujepa -- was approved for the treatment of uncomplicated urinary tract infections in adult women and ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results